▶ 調査レポート

十字靭帯診断・治療の世界市場(~2026年)

• 英文タイトル:Global Cruciate Ligament Diagnosis and Treatment Market Size, Status and Forecast 2020-2026

QYResearchが調査・発行した産業分析レポートです。十字靭帯診断・治療の世界市場(~2026年) / Global Cruciate Ligament Diagnosis and Treatment Market Size, Status and Forecast 2020-2026 / MRC2-11QY11535資料のイメージです。• レポートコード:MRC2-11QY11535
• 出版社/出版日:QYResearch / 2020年11月25日
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、98ページ
• 納品方法:Eメール(納期:2~3日)
• 産業分類:ヘルスケア
• 販売価格(消費税別)
  Single User¥546,000 (USD3,900)▷ お問い合わせ
  Multi User¥819,000 (USD5,850)▷ お問い合わせ
  Enterprise License¥1,092,000 (USD7,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
当調査資料は十字靭帯診断・治療のグローバル市場について調査・分析したレポートです。種類別(後十字靭帯(PCL)、前十字靭帯(ACL))市場規模、用途別(病院、整形外科クリニック、外来手術センター(ASC))市場規模、地域別(北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等)市場規模データ、主な企業情報と企業別市場シェア等が収録されています。
・調査範囲
・エグゼクティブサマリー
・企業別十字靭帯診断・治療の競争状況、市場シェア
・世界の十字靭帯診断・治療市場:種類別市場規模 2015年-2020年(後十字靭帯(PCL)、前十字靭帯(ACL))
・世界の十字靭帯診断・治療市場:種類別市場規模予測 2021年-2026年(後十字靭帯(PCL)、前十字靭帯(ACL))
・世界の十字靭帯診断・治療市場:用途別市場規模 2015年-2020年(病院、整形外科クリニック、外来手術センター(ASC))
・世界の十字靭帯診断・治療市場:用途別市場規模予測 2021年-2026年(病院、整形外科クリニック、外来手術センター(ASC))
・北米の十字靭帯診断・治療市場分析:米国、カナダ
・ヨーロッパの十字靭帯診断・治療市場分析:ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアの十字靭帯診断・治療市場分析:日本、中国、韓国、インド、オーストラリア、台湾等
・中南米の十字靭帯診断・治療市場分析:メキシコ、ブラジル、アルゼンチン等
・中東・アフリカの十字靭帯診断・治療市場分析:トルコ、サウジアラビア、UAE等
・企業情報(企業概要、製品概要、販売量、企業動向)
- 掲載企業(変更可能性あり):Stryker、Arthrex、Zimmer Biomet、DePuy Synthes、Conmed、Smith & Nephew、3M、DJO Global、Breg、Bauerfeind AG、DeRoyal Industries、BSN Medical GmbH
・地域別市場規模予測(2021年-2026年):北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論

A ligament is a band of tissue that holds the bones together, keeping the knee stable. Primarily these ligaments are broadly classified into cruciate ligament and collateral ligament. Further, these are divided into four primary ligaments, namely, Anterior Cruciate Ligament (ACL), Posterior Cruciate Ligament (PCL), Medial Collateral Ligament (MCL), and Lateral Collateral Ligament (LCL). The cruciate ligaments, i.e., the PCL and ACL are crossed ligaments that stabilize the joint while allowing a very large range of motion. Knee injuries are usually the most common musculoskeletal traumas among people, where the Anterior Cruciate Ligament (ACL) injury is one of the utmost frequent occurring knee injuries. Surgical reconstruction is the standard gold treatment for treating knee injuries. Increasing incidences of sports-related injuries have become a leading cause of soft tissue injuries worldwide. Athletes are most likely to injure the ACLs disabling complete stretching of their legs. A type of surgery that involves reconstruction of the ligament is known as ACL reconstruction that lies in the center of one’s knee with a graft.
The Americas dominates the cruciate ligament diagnosis and treatment market owing to the rising prevalence of osteoarthritis among the elderly population, well-developed surgical technology, high healthcare expenditure, and the presence of the leading players.

Market Analysis and Insights: Global Cruciate Ligament Diagnosis and Treatment Market
The global Cruciate Ligament Diagnosis and Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Cruciate Ligament Diagnosis and Treatment Scope and Market Size
Cruciate Ligament Diagnosis and Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Cruciate Ligament Diagnosis and Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
Stryker
Arthrex
Zimmer Biomet
DePuy Synthes
Conmed
Smith & Nephew
3M
DJO Global
Breg
Bauerfeind AG
DeRoyal Industries
BSN Medical GmbH

Market segment by Type, the product can be split into
Posterior Cruciate Ligament (PCL)
Anterior Cruciate Ligament (ACL)
Market segment by Application, split into
Hospitals
Orthopedic Clinics
Ambulatory Surgical Center (ASC)

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Cruciate Ligament Diagnosis and Treatment Revenue
1.4 Market by Type
1.4.1 Global Cruciate Ligament Diagnosis and Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Posterior Cruciate Ligament (PCL)
1.4.3 Anterior Cruciate Ligament (ACL)
1.5 Market by Application
1.5.1 Global Cruciate Ligament Diagnosis and Treatment Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Orthopedic Clinics
1.5.4 Ambulatory Surgical Center (ASC)
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Global Cruciate Ligament Diagnosis and Treatment Market Perspective (2015-2026)
2.2 Global Cruciate Ligament Diagnosis and Treatment Growth Trends by Regions
2.2.1 Cruciate Ligament Diagnosis and Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Cruciate Ligament Diagnosis and Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Cruciate Ligament Diagnosis and Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Cruciate Ligament Diagnosis and Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Cruciate Ligament Diagnosis and Treatment Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Cruciate Ligament Diagnosis and Treatment Players by Market Size
3.1.1 Global Top Cruciate Ligament Diagnosis and Treatment Players by Revenue (2015-2020)
3.1.2 Global Cruciate Ligament Diagnosis and Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global Cruciate Ligament Diagnosis and Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Cruciate Ligament Diagnosis and Treatment Market Concentration Ratio
3.2.1 Global Cruciate Ligament Diagnosis and Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Cruciate Ligament Diagnosis and Treatment Revenue in 2019
3.3 Cruciate Ligament Diagnosis and Treatment Key Players Head office and Area Served
3.4 Key Players Cruciate Ligament Diagnosis and Treatment Product Solution and Service
3.5 Date of Enter into Cruciate Ligament Diagnosis and Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Cruciate Ligament Diagnosis and Treatment Historic Market Size by Type (2015-2020)
4.2 Global Cruciate Ligament Diagnosis and Treatment Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)
5.1 Global Cruciate Ligament Diagnosis and Treatment Market Size by Application (2015-2020)
5.2 Global Cruciate Ligament Diagnosis and Treatment Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Cruciate Ligament Diagnosis and Treatment Market Size (2015-2020)
6.2 Cruciate Ligament Diagnosis and Treatment Key Players in North America (2019-2020)
6.3 North America Cruciate Ligament Diagnosis and Treatment Market Size by Type (2015-2020)
6.4 North America Cruciate Ligament Diagnosis and Treatment Market Size by Application (2015-2020)

7 Europe
7.1 Europe Cruciate Ligament Diagnosis and Treatment Market Size (2015-2020)
7.2 Cruciate Ligament Diagnosis and Treatment Key Players in Europe (2019-2020)
7.3 Europe Cruciate Ligament Diagnosis and Treatment Market Size by Type (2015-2020)
7.4 Europe Cruciate Ligament Diagnosis and Treatment Market Size by Application (2015-2020)

8 China
8.1 China Cruciate Ligament Diagnosis and Treatment Market Size (2015-2020)
8.2 Cruciate Ligament Diagnosis and Treatment Key Players in China (2019-2020)
8.3 China Cruciate Ligament Diagnosis and Treatment Market Size by Type (2015-2020)
8.4 China Cruciate Ligament Diagnosis and Treatment Market Size by Application (2015-2020)

9 Japan
9.1 Japan Cruciate Ligament Diagnosis and Treatment Market Size (2015-2020)
9.2 Cruciate Ligament Diagnosis and Treatment Key Players in Japan (2019-2020)
9.3 Japan Cruciate Ligament Diagnosis and Treatment Market Size by Type (2015-2020)
9.4 Japan Cruciate Ligament Diagnosis and Treatment Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Cruciate Ligament Diagnosis and Treatment Market Size (2015-2020)
10.2 Cruciate Ligament Diagnosis and Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Cruciate Ligament Diagnosis and Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Cruciate Ligament Diagnosis and Treatment Market Size by Application (2015-2020)

11 India
11.1 India Cruciate Ligament Diagnosis and Treatment Market Size (2015-2020)
11.2 Cruciate Ligament Diagnosis and Treatment Key Players in India (2019-2020)
11.3 India Cruciate Ligament Diagnosis and Treatment Market Size by Type (2015-2020)
11.4 India Cruciate Ligament Diagnosis and Treatment Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Cruciate Ligament Diagnosis and Treatment Market Size (2015-2020)
12.2 Cruciate Ligament Diagnosis and Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Cruciate Ligament Diagnosis and Treatment Market Size by Type (2015-2020)
12.4 Central & South America Cruciate Ligament Diagnosis and Treatment Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 Stryker
13.1.1 Stryker Company Details
13.1.2 Stryker Business Overview
13.1.3 Stryker Cruciate Ligament Diagnosis and Treatment Introduction
13.1.4 Stryker Revenue in Cruciate Ligament Diagnosis and Treatment Business (2015-2020))
13.1.5 Stryker Recent Development
13.2 Arthrex
13.2.1 Arthrex Company Details
13.2.2 Arthrex Business Overview
13.2.3 Arthrex Cruciate Ligament Diagnosis and Treatment Introduction
13.2.4 Arthrex Revenue in Cruciate Ligament Diagnosis and Treatment Business (2015-2020)
13.2.5 Arthrex Recent Development
13.3 Zimmer Biomet
13.3.1 Zimmer Biomet Company Details
13.3.2 Zimmer Biomet Business Overview
13.3.3 Zimmer Biomet Cruciate Ligament Diagnosis and Treatment Introduction
13.3.4 Zimmer Biomet Revenue in Cruciate Ligament Diagnosis and Treatment Business (2015-2020)
13.3.5 Zimmer Biomet Recent Development
13.4 DePuy Synthes
13.4.1 DePuy Synthes Company Details
13.4.2 DePuy Synthes Business Overview
13.4.3 DePuy Synthes Cruciate Ligament Diagnosis and Treatment Introduction
13.4.4 DePuy Synthes Revenue in Cruciate Ligament Diagnosis and Treatment Business (2015-2020)
13.4.5 DePuy Synthes Recent Development
13.5 Conmed
13.5.1 Conmed Company Details
13.5.2 Conmed Business Overview
13.5.3 Conmed Cruciate Ligament Diagnosis and Treatment Introduction
13.5.4 Conmed Revenue in Cruciate Ligament Diagnosis and Treatment Business (2015-2020)
13.5.5 Conmed Recent Development
13.6 Smith & Nephew
13.6.1 Smith & Nephew Company Details
13.6.2 Smith & Nephew Business Overview
13.6.3 Smith & Nephew Cruciate Ligament Diagnosis and Treatment Introduction
13.6.4 Smith & Nephew Revenue in Cruciate Ligament Diagnosis and Treatment Business (2015-2020)
13.6.5 Smith & Nephew Recent Development
13.7 3M
13.7.1 3M Company Details
13.7.2 3M Business Overview
13.7.3 3M Cruciate Ligament Diagnosis and Treatment Introduction
13.7.4 3M Revenue in Cruciate Ligament Diagnosis and Treatment Business (2015-2020)
13.7.5 3M Recent Development
13.8 DJO Global
13.8.1 DJO Global Company Details
13.8.2 DJO Global Business Overview
13.8.3 DJO Global Cruciate Ligament Diagnosis and Treatment Introduction
13.8.4 DJO Global Revenue in Cruciate Ligament Diagnosis and Treatment Business (2015-2020)
13.8.5 DJO Global Recent Development
13.9 Breg
13.9.1 Breg Company Details
13.9.2 Breg Business Overview
13.9.3 Breg Cruciate Ligament Diagnosis and Treatment Introduction
13.9.4 Breg Revenue in Cruciate Ligament Diagnosis and Treatment Business (2015-2020)
13.9.5 Breg Recent Development
13.10 Bauerfeind AG
13.10.1 Bauerfeind AG Company Details
13.10.2 Bauerfeind AG Business Overview
13.10.3 Bauerfeind AG Cruciate Ligament Diagnosis and Treatment Introduction
13.10.4 Bauerfeind AG Revenue in Cruciate Ligament Diagnosis and Treatment Business (2015-2020)
13.10.5 Bauerfeind AG Recent Development
13.11 DeRoyal Industries
10.11.1 DeRoyal Industries Company Details
10.11.2 DeRoyal Industries Business Overview
10.11.3 DeRoyal Industries Cruciate Ligament Diagnosis and Treatment Introduction
10.11.4 DeRoyal Industries Revenue in Cruciate Ligament Diagnosis and Treatment Business (2015-2020)
10.11.5 DeRoyal Industries Recent Development
13.12 BSN Medical GmbH
10.12.1 BSN Medical GmbH Company Details
10.12.2 BSN Medical GmbH Business Overview
10.12.3 BSN Medical GmbH Cruciate Ligament Diagnosis and Treatment Introduction
10.12.4 BSN Medical GmbH Revenue in Cruciate Ligament Diagnosis and Treatment Business (2015-2020)
10.12.5 BSN Medical GmbH Recent Development

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List of Tables
Table 1. Cruciate Ligament Diagnosis and Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Cruciate Ligament Diagnosis and Treatment Revenue
Table 3. Ranking of Global Top Cruciate Ligament Diagnosis and Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Cruciate Ligament Diagnosis and Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Posterior Cruciate Ligament (PCL)
Table 6. Key Players of Anterior Cruciate Ligament (ACL)
Table 7. Global Cruciate Ligament Diagnosis and Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Cruciate Ligament Diagnosis and Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Cruciate Ligament Diagnosis and Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Cruciate Ligament Diagnosis and Treatment Market Share by Regions (2015-2020)
Table 11. Global Cruciate Ligament Diagnosis and Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Cruciate Ligament Diagnosis and Treatment Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. Cruciate Ligament Diagnosis and Treatment Market Growth Strategy
Table 17. Main Points Interviewed from Key Cruciate Ligament Diagnosis and Treatment Players
Table 18. Global Cruciate Ligament Diagnosis and Treatment Revenue by Players (2015-2020) (Million US$)
Table 19. Global Cruciate Ligament Diagnosis and Treatment Market Share by Players (2015-2020)
Table 20. Global Top Cruciate Ligament Diagnosis and Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cruciate Ligament Diagnosis and Treatment as of 2019)
Table 21. Global Cruciate Ligament Diagnosis and Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Cruciate Ligament Diagnosis and Treatment Product Solution and Service
Table 24. Date of Enter into Cruciate Ligament Diagnosis and Treatment Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Cruciate Ligament Diagnosis and Treatment Market Size by Type (2015-2020) (Million US$)
Table 27. Global Cruciate Ligament Diagnosis and Treatment Market Size Share by Type (2015-2020)
Table 28. Global Cruciate Ligament Diagnosis and Treatment Revenue Market Share by Type (2021-2026)
Table 29. Global Cruciate Ligament Diagnosis and Treatment Market Size Share by Application (2015-2020)
Table 30. Global Cruciate Ligament Diagnosis and Treatment Market Size by Application (2015-2020) (Million US$)
Table 31. Global Cruciate Ligament Diagnosis and Treatment Market Size Share by Application (2021-2026)
Table 32. North America Key Players Cruciate Ligament Diagnosis and Treatment Revenue (2019-2020) (Million US$)
Table 33. North America Key Players Cruciate Ligament Diagnosis and Treatment Market Share (2019-2020)
Table 34. North America Cruciate Ligament Diagnosis and Treatment Market Size by Type (2015-2020) (Million US$)
Table 35. North America Cruciate Ligament Diagnosis and Treatment Market Share by Type (2015-2020)
Table 36. North America Cruciate Ligament Diagnosis and Treatment Market Size by Application (2015-2020) (Million US$)
Table 37. North America Cruciate Ligament Diagnosis and Treatment Market Share by Application (2015-2020)
Table 38. Europe Key Players Cruciate Ligament Diagnosis and Treatment Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players Cruciate Ligament Diagnosis and Treatment Market Share (2019-2020)
Table 40. Europe Cruciate Ligament Diagnosis and Treatment Market Size by Type (2015-2020) (Million US$)
Table 41. Europe Cruciate Ligament Diagnosis and Treatment Market Share by Type (2015-2020)
Table 42. Europe Cruciate Ligament Diagnosis and Treatment Market Size by Application (2015-2020) (Million US$)
Table 43. Europe Cruciate Ligament Diagnosis and Treatment Market Share by Application (2015-2020)
Table 44. China Key Players Cruciate Ligament Diagnosis and Treatment Revenue (2019-2020) (Million US$)
Table 45. China Key Players Cruciate Ligament Diagnosis and Treatment Market Share (2019-2020)
Table 46. China Cruciate Ligament Diagnosis and Treatment Market Size by Type (2015-2020) (Million US$)
Table 47. China Cruciate Ligament Diagnosis and Treatment Market Share by Type (2015-2020)
Table 48. China Cruciate Ligament Diagnosis and Treatment Market Size by Application (2015-2020) (Million US$)
Table 49. China Cruciate Ligament Diagnosis and Treatment Market Share by Application (2015-2020)
Table 50. Japan Key Players Cruciate Ligament Diagnosis and Treatment Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players Cruciate Ligament Diagnosis and Treatment Market Share (2019-2020)
Table 52. Japan Cruciate Ligament Diagnosis and Treatment Market Size by Type (2015-2020) (Million US$)
Table 53. Japan Cruciate Ligament Diagnosis and Treatment Market Share by Type (2015-2020)
Table 54. Japan Cruciate Ligament Diagnosis and Treatment Market Size by Application (2015-2020) (Million US$)
Table 55. Japan Cruciate Ligament Diagnosis and Treatment Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players Cruciate Ligament Diagnosis and Treatment Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players Cruciate Ligament Diagnosis and Treatment Market Share (2019-2020)
Table 58. Southeast Asia Cruciate Ligament Diagnosis and Treatment Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia Cruciate Ligament Diagnosis and Treatment Market Share by Type (2015-2020)
Table 60. Southeast Asia Cruciate Ligament Diagnosis and Treatment Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia Cruciate Ligament Diagnosis and Treatment Market Share by Application (2015-2020)
Table 62. India Key Players Cruciate Ligament Diagnosis and Treatment Revenue (2019-2020) (Million US$)
Table 63. India Key Players Cruciate Ligament Diagnosis and Treatment Market Share (2019-2020)
Table 64. India Cruciate Ligament Diagnosis and Treatment Market Size by Type (2015-2020) (Million US$)
Table 65. India Cruciate Ligament Diagnosis and Treatment Market Share by Type (2015-2020)
Table 66. India Cruciate Ligament Diagnosis and Treatment Market Size by Application (2015-2020) (Million US$)
Table 67. India Cruciate Ligament Diagnosis and Treatment Market Share by Application (2015-2020)
Table 68. Central & South America Key Players Cruciate Ligament Diagnosis and Treatment Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players Cruciate Ligament Diagnosis and Treatment Market Share (2019-2020)
Table 70. Central & South America Cruciate Ligament Diagnosis and Treatment Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America Cruciate Ligament Diagnosis and Treatment Market Share by Type (2015-2020)
Table 72. Central & South America Cruciate Ligament Diagnosis and Treatment Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America Cruciate Ligament Diagnosis and Treatment Market Share by Application (2015-2020)
Table 74. Stryker Company Details
Table 75. Stryker Business Overview
Table 76. Stryker Product
Table 77. Stryker Revenue in Cruciate Ligament Diagnosis and Treatment Business (2015-2020) (Million US$)
Table 78. Stryker Recent Development
Table 79. Arthrex Company Details
Table 80. Arthrex Business Overview
Table 81. Arthrex Product
Table 82. Arthrex Revenue in Cruciate Ligament Diagnosis and Treatment Business (2015-2020) (Million US$)
Table 83. Arthrex Recent Development
Table 84. Zimmer Biomet Company Details
Table 85. Zimmer Biomet Business Overview
Table 86. Zimmer Biomet Product
Table 87. Zimmer Biomet Revenue in Cruciate Ligament Diagnosis and Treatment Business (2015-2020) (Million US$)
Table 88. Zimmer Biomet Recent Development
Table 89. DePuy Synthes Company Details
Table 90. DePuy Synthes Business Overview
Table 91. DePuy Synthes Product
Table 92. DePuy Synthes Revenue in Cruciate Ligament Diagnosis and Treatment Business (2015-2020) (Million US$)
Table 93. DePuy Synthes Recent Development
Table 94. Conmed Company Details
Table 95. Conmed Business Overview
Table 96. Conmed Product
Table 97. Conmed Revenue in Cruciate Ligament Diagnosis and Treatment Business (2015-2020) (Million US$)
Table 98. Conmed Recent Development
Table 99. Smith & Nephew Company Details
Table 100. Smith & Nephew Business Overview
Table 101. Smith & Nephew Product
Table 102. Smith & Nephew Revenue in Cruciate Ligament Diagnosis and Treatment Business (2015-2020) (Million US$)
Table 103. Smith & Nephew Recent Development
Table 104. 3M Company Details
Table 105. 3M Business Overview
Table 106. 3M Product
Table 107. 3M Revenue in Cruciate Ligament Diagnosis and Treatment Business (2015-2020) (Million US$)
Table 108. 3M Recent Development
Table 109. DJO Global Business Overview
Table 110. DJO Global Product
Table 111. DJO Global Company Details
Table 112. DJO Global Revenue in Cruciate Ligament Diagnosis and Treatment Business (2015-2020) (Million US$)
Table 113. DJO Global Recent Development
Table 114. Breg Company Details
Table 115. Breg Business Overview
Table 116. Breg Product
Table 117. Breg Revenue in Cruciate Ligament Diagnosis and Treatment Business (2015-2020) (Million US$)
Table 118. Breg Recent Development
Table 119. Bauerfeind AG Company Details
Table 120. Bauerfeind AG Business Overview
Table 121. Bauerfeind AG Product
Table 122. Bauerfeind AG Revenue in Cruciate Ligament Diagnosis and Treatment Business (2015-2020) (Million US$)
Table 123. Bauerfeind AG Recent Development
Table 124. DeRoyal Industries Company Details
Table 125. DeRoyal Industries Business Overview
Table 126. DeRoyal Industries Product
Table 127. DeRoyal Industries Revenue in Cruciate Ligament Diagnosis and Treatment Business (2015-2020) (Million US$)
Table 128. DeRoyal Industries Recent Development
Table 129. BSN Medical GmbH Company Details
Table 130. BSN Medical GmbH Business Overview
Table 131. BSN Medical GmbH Product
Table 132. BSN Medical GmbH Revenue in Cruciate Ligament Diagnosis and Treatment Business (2015-2020) (Million US$)
Table 133. BSN Medical GmbH Recent Development
Table 134. Research Programs/Design for This Report
Table 135. Key Data Information from Secondary Sources
Table 136. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cruciate Ligament Diagnosis and Treatment Market Share by Type: 2020 VS 2026
Figure 2. Posterior Cruciate Ligament (PCL) Features
Figure 3. Anterior Cruciate Ligament (ACL) Features
Figure 4. Global Cruciate Ligament Diagnosis and Treatment Market Share by Application: 2020 VS 2026
Figure 5. Hospitals Case Studies
Figure 6. Orthopedic Clinics Case Studies
Figure 7. Ambulatory Surgical Center (ASC) Case Studies
Figure 8. Cruciate Ligament Diagnosis and Treatment Report Years Considered
Figure 9. Global Cruciate Ligament Diagnosis and Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global Cruciate Ligament Diagnosis and Treatment Market Share by Regions: 2020 VS 2026
Figure 11. Global Cruciate Ligament Diagnosis and Treatment Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global Cruciate Ligament Diagnosis and Treatment Market Share by Players in 2019
Figure 14. Global Top Cruciate Ligament Diagnosis and Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cruciate Ligament Diagnosis and Treatment as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Cruciate Ligament Diagnosis and Treatment Revenue in 2019
Figure 16. North America Cruciate Ligament Diagnosis and Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe Cruciate Ligament Diagnosis and Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. China Cruciate Ligament Diagnosis and Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Japan Cruciate Ligament Diagnosis and Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Southeast Asia Cruciate Ligament Diagnosis and Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. India Cruciate Ligament Diagnosis and Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Central & South America Cruciate Ligament Diagnosis and Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Bottom-up and Top-down Approaches for This Report
Figure 24. Data Triangulation
Figure 25. Key Executives Interviewed